Full Text View
Tabular View
No Study Results Posted
Related Studies
Long-Term Antibody Persistence at 1, 3 and 5 Years After a Booster Dose of GSKBiologicals Hib-MenCY-TT Vaccine Compared to ActHIB
This study is ongoing, but not recruiting participants.
Study NCT00359983   Information provided by GlaxoSmithKline
First Received: July 31, 2006   Last Updated: September 2, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Meningococcal Infections
Additional conditions recognized in this trial
Communicable Diseases
Infection
Influenza, Human
More general conditions related to this trial
Bacterial Infections
Gram-Negative Bacterial Infections
Neisseriaceae Infections
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Hib conjugate vaccine
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services